Skip to main content

Table 1 Molecular characteristics of the 34 xenografts

From: Interplay of choline metabolites and genes in patient-derived breast cancer xenografts

 

Intrinsic molecular subtype

Receptor status

Histological classification

Metastasis

Model

Basal-like

Luminal B

Luminal A

HER2 enriched

Unknown

ER pos.

PgR pos.

HER2 pos.

IDC

ILC

ICC

DCIS

IMPC

Node

Distant

HBCx-1

X

       

X

      

HBCx-4B

X

       

X

    

X

 

HBCx-7

X

        

X

    

X

HBCx-8

X

       

X

      

HBCx-9

X

       

X

      

HBCx-10

X

       

X

      

HBCx-12A

X

       

X

      

HBCx-12B

X

       

X

    

X

 

HBCx-14

X

       

X

      

HBCx-15

X

       

X

      

HBCx-16

X

       

X

      

HBCx-17

X

       

X

      

HBCx-24

X

       

X

      

HBCx-27

X

       

X

      

HBCx-28

X

       

X

      

HBCx-30

X

       

X

      

HBCx-39

X

       

X

      

HBCx-41

X

      

X

    

X

  

MAS98.12

X

       

X

      

HBCx-3

 

X

   

X

  

X

      

HBCx-5

 

X

   

X

 

X

X

    

X

 

HBCx-19

 

X

       

X

    

X

HBCx-26

 

X

   

X

 

X

X

      

HBCx-31

 

X

      

X

      

HBCx-34

 

X

   

X

X

 

X

      

MAS98.06

 

X

   

X

X

 

X

      

HBCx-21

  

X

  

X

X

    

X

   

HBCx-13A

   

X

   

X

X

      

HBCx-13B

   

X

   

X

X

    

X

 

HBCx-40

   

X

    

X

      

HBCx-11

    

X

     

X

    

HBCx-23

    

X

   

X

      

HBCx-29

    

X

X

X

X

X

      

HBCx-33

    

X

   

X

      

Total numbers

19

7

1

3

4

7

4

6

29

2

1

1

1

4

2

  1. The table reports on intrinsic molecular subtype, receptor status, histological classification and metastatic potential.
  2. DCIS, ductal in citu carcinoma; ER, estrogen receptor; HER2, human epidermal growth factor receptor 2; ICC, invasive cribriform carcinoma; IDC, invasive ductal carcinoma; ILC, invasive lobular carcinoma; IMPC, invasive micropapillary carcinoma; PgR, progesterone receptor